Press release
Unlocking Opportunities in the Melanoma Therapeutics Market: 2025-2034 Forecast Report
Melanoma Therapeutics Market
What Will the Melanoma Therapeutics Industry Market Size Be by 2025?
The size of the melanoma therapeutics market has witnessed rapid expansion in the past few years. There will be an increase from $4.05 billion in 2024 to $4.47 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.4%. Factors such as changes in treatment guidelines, higher awareness leading to early detection, regulatory approvals along with clinical trials, emergence of combination therapies, and improvements in surgical methods accounted for this growth during the historical period.
What's the Long-Term Growth Forecast for the Melanoma Therapeutics Market Size Through 2029?
The market for melanoma treatments is anticipated to witness a significant surge in the coming years, escalating to "$6.72 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. The factors contributing to the market progression in the projection period can be credited to the advent of new treatment methods, introduction of biomarkers, supportive regulatory framework for innovation, advancements in tailored medicine and improvements in immunotherapy. The emerging trends during the forecast period will encompass the transformation of treatment protocols, application of telemedicine in cancer treatment, patient advocacy and awareness initiatives, biomarker studies, and combination therapies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/melanoma-therapeutics-global-market-report
What Are the Key Growth Drivers Fueling the Melanoma Therapeutics Market Expansion?
The melanoma therapeutics market is anticipated to experience growth due to the rising occurrences of melanoma. Melanoma is a form of skin cancer that originates in melanocytes, and melanoma therapeutics are the treatment methods and medications utilized to relieve melanoma patients of this cancer. Consequently, the growth in melanoma cases is directly contributing to the increase in sales of melanoma therapeutic treatments. To illustrate, a report by the Australian Institute of Health and Welfare in August 2024 shows that around 209,000 new cancer diagnoses are expected in Australia by 2034, a substantial rise from the projected 169,000 cases in 2024. This increase is indicative of the expanding population and increasing cancer rates. Furthermore, it is foreseen that, in 2024, cancer is likely to cause around 30% of all deaths in Australia. Hence, the escalation in melanoma cases is stimulating the growth of the melanoma therapeutics drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10713&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Melanoma Therapeutics Market?
One of the leading trends emerging in the melanoma therapeutics market is product innovation. Prominent companies in this sector are creating novel therapies to secure their market standing. For instance, KIMMTRAK (tebentafusp-tebn), developed by UK biotech firm Immunocore in January 2022, was approved by the FDA for the treatment of metastatic uveal melanoma. After a positive phase 3 clinical trial, KIMMTRAK, which is the first and only approved therapy for unresectable or metastatic uveal melanoma, showed a nearly 22-month overall survival rate. The drug is a unique bispecific protein that combines anti-CD3 immune-effector activity with a soluble T cell receptor. This inaugural compound developed using Immunocore's ImmTAC technology is designed to direct and activate T lymphocytes in order to recognize and eradicate cancer cells.
How Is the Melanoma Therapeutics Market Segmented?
The melanoma therapeutics market covered in this report is segmented -
1) By Drug Type: Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types
2) By Therapy: Surgery, Radiation Therapy, Immunotherapy, Targeted Therapy, Chemotherapy
3) By Route of administration: Oral, Injectable
4) By Cancer Type: Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna Melanoma, Acral Lentiginous Melanoma, Amelanotic Melanoma, Other Cancer Types
5) By Diagnosis: Dermatoscopy, Sentinel Lymph Node Biopsy, Blood Test, X-ray, Ultrasound, CT Scan
Subsegments:
1) By Monoclonal Antibodies: Checkpoint Inhibitors, Targeted Monoclonal Antibodies, Conjugated Antibodies
2) By Small Molecule Inhibitors: BRAF Inhibitors, MEK Inhibitors, Other Kinase Inhibitors
3) By Other Drug Types: Chemotherapy Agents, Immunotherapy Agents, Adjuvant Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10713&type=smp
Which Companies Are Leading the Charge in Melanoma Therapeutics Market Innovation?
Major companies operating in the melanoma therapeutics market include AstraZeneca plc, Eli Lilly and Company, Merck & Co. Inc., Novartis AG, Sanofi S.A., AB Science S.A, Amgen Inc., Daiichi Sankyo Company Limited, F. Hoffman-La Roche Ltd., Pfizer Inc., Bayer AG, AbbVie Inc., Johnson & Johnson Private Limited, The Bristol-Myers Squibb Company, Nektar Therapeutics, Immutep Ltd., Partner Therapeutics lnc., Idera Pharmaceuticals Inc., Oncolys BioPharma Inc., Iovance Biotherapeutics lnc., AIM ImmunoTech Inc., Infinity Pharmaceuticals lnc., Spring Bank Pharmaceuticals lnc., Incyte Corporation, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Eisai Co.Ltd., Seattle Genetics Inc., Regeneron Pharmaceuticals Inc., Bio-Rad Laboratories Inc., Myriad Genetics Inc.
Which Regions Are Leading the Global Melanoma Therapeutics Market in Revenue?
North America was the largest region in the melanoma therapeutics market in 2024. The regions covered in the melanoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10713
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlocking Opportunities in the Melanoma Therapeutics Market: 2025-2034 Forecast Report here
News-ID: 4180512 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
